View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAlbioma 배당 및 자사주 매입배당 기준 점검 3/6핵심 정보1.8%배당 수익률0.1%자사주 매입 수익률총 주주 수익률1.9%미래 배당 수익률2.2%배당 성장률7.2%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향47%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 18% share price gain to €45.60, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 139% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €30.87 per share.Reported Earnings • Mar 03Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.88 (up from €1.78 in FY 2020). Revenue: €573.3m (up 13% from FY 2020). Net income: €59.0m (up 6.7% from FY 2020). Profit margin: 10% (in line with FY 2020). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 1.6%, compared to a 14% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to €40.86, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 130% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.96 per share.분석 기사 • Feb 27Returns On Capital At Albioma (EPA:ABIO) Have StalledIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...분석 기사 • Nov 23Albioma (EPA:ABIO) Has More To Do To Multiply In Value Going ForwardThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...분석 기사 • Oct 18Is Albioma (EPA:ABIO) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Aug 19Albioma's (EPA:ABIO) Returns Have Hit A WallIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Reported Earnings • Jul 30First half 2021 earnings released: EPS €0.75 (vs €0.79 in 1H 2020)The company reported a mediocre first half result with weaker earnings, although profit margins were flat and revenues improved. First half 2021 results: Revenue: €267.7m (up 6.8% from 1H 2020). Net income: €23.5m (down 3.5% from 1H 2020). Profit margin: 8.8% (in line with 1H 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).분석 기사 • May 12Albioma's (EPA:ABIO) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...분석 기사 • Apr 28Is Albioma (EPA:ABIO) Worth €39.2 Based On Its Intrinsic Value?Does the April share price for Albioma ( EPA:ABIO ) reflect what it's really worth? Today, we will estimate the stock's...분석 기사 • Mar 25These 4 Measures Indicate That Albioma (EPA:ABIO) Is Using Debt ExtensivelyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Mar 07Is Albioma (EPA:ABIO) A High Quality Stock To Own?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...Reported Earnings • Mar 06Full year 2020 earnings released: EPS €1.78 (vs €1.44 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: €506.7m (flat on FY 2019). Net income: €55.3m (up 25% from FY 2019). Profit margin: 11% (up from 8.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.Analyst Estimate Surprise Post Earnings • Mar 06Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 12%. Over the next year, revenue is forecast to grow 4.3%, compared to a 42% growth forecast for the Renewable Energy industry in France.Price Target Changed • Mar 05Price target raised to €50.86Up from €47.43, the current price target is an average from 7 analysts. The new target price is 27% above the current share price of €40.00. As of last close, the stock is up 12% over the past year.Is New 90 Day High Low • Feb 25New 90-day low: €40.50The company is down 2.0% from its price of €41.35 on 26 November 2020. The French market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.48 per share.분석 기사 • Feb 18Albioma (EPA:ABIO) Has Rewarded Shareholders With An Exceptional 332% Total Return On Their InvestmentWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...분석 기사 • Jan 23Is Albioma (EPA:ABIO) Likely To Turn Things Around?If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Jan 05What Kind Of Shareholders Own Albioma (EPA:ABIO)?Every investor in Albioma ( EPA:ABIO ) should be aware of the most powerful shareholder groups. Generally speaking, as...Is New 90 Day High Low • Jan 04New 90-day high: €47.90The company is up 6.0% from its price of €45.10 on 06 October 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €20.68 per share.분석 기사 • Dec 19At €43.80, Is It Time To Put Albioma (EPA:ABIO) On Your Watch List?Albioma ( EPA:ABIO ), is not the largest company out there, but it saw a decent share price growth in the teens level...분석 기사 • Dec 06A Closer Look At Albioma's (EPA:ABIO) Impressive ROEOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...분석 기사 • Nov 22How Is Albioma's (EPA:ABIO) CEO Paid Relative To Peers?This article will reflect on the compensation paid to Frédéric Moyne who has served as CEO of Albioma (EPA:ABIO) since...Price Target Changed • Oct 30Price target raised to €45.63Up from €41.20, the current price target is an average from 7 analysts. The new target price is 14% above the current share price of €39.95. As of last close, the stock is up 71% over the past year.Is New 90 Day High Low • Oct 08New 90-day high: €45.65The company is up 16% from its price of €39.35 on 09 July 2020. The French market is flat over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Renewable Energy industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €19.25 per share.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: ABIO 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.배당금 증가: ABIO 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Albioma 배당 수익률 vs 시장ABIO의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ABIO)1.8%시장 하위 25% (FR)2.0%시장 상위 25% (FR)5.3%업계 평균 (Renewable Energy)2.3%분석가 예측 (ABIO) (최대 3년)2.2%주목할만한 배당금: ABIO 의 배당금( 1.78% )은 French 시장에서 배당금 지급자의 하위 25%( 1.97% )와 비교해 주목할 만하지 않습니다.고배당: ABIO 의 배당금( 1.78% )은 French 시장에서 배당금 지급자의 상위 25%( 5.34% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 47.1% )로 ABIO 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: ABIO 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YFR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2022/10/13 04:39종가2022/09/13 00:00수익2022/06/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Albioma는 13명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yohann TerryBNP ParibasCaroline CohenBofA Global ResearchEmmanuel ChevalierCIC Market Solutions (ESN)10명의 분석가 더 보기
Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 18% share price gain to €45.60, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 139% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €30.87 per share.
Reported Earnings • Mar 03Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.88 (up from €1.78 in FY 2020). Revenue: €573.3m (up 13% from FY 2020). Net income: €59.0m (up 6.7% from FY 2020). Profit margin: 10% (in line with FY 2020). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 1.6%, compared to a 14% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to €40.86, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 130% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.96 per share.
분석 기사 • Feb 27Returns On Capital At Albioma (EPA:ABIO) Have StalledIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
분석 기사 • Nov 23Albioma (EPA:ABIO) Has More To Do To Multiply In Value Going ForwardThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
분석 기사 • Oct 18Is Albioma (EPA:ABIO) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Aug 19Albioma's (EPA:ABIO) Returns Have Hit A WallIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Reported Earnings • Jul 30First half 2021 earnings released: EPS €0.75 (vs €0.79 in 1H 2020)The company reported a mediocre first half result with weaker earnings, although profit margins were flat and revenues improved. First half 2021 results: Revenue: €267.7m (up 6.8% from 1H 2020). Net income: €23.5m (down 3.5% from 1H 2020). Profit margin: 8.8% (in line with 1H 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).
분석 기사 • May 12Albioma's (EPA:ABIO) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
분석 기사 • Apr 28Is Albioma (EPA:ABIO) Worth €39.2 Based On Its Intrinsic Value?Does the April share price for Albioma ( EPA:ABIO ) reflect what it's really worth? Today, we will estimate the stock's...
분석 기사 • Mar 25These 4 Measures Indicate That Albioma (EPA:ABIO) Is Using Debt ExtensivelyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Mar 07Is Albioma (EPA:ABIO) A High Quality Stock To Own?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Reported Earnings • Mar 06Full year 2020 earnings released: EPS €1.78 (vs €1.44 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: €506.7m (flat on FY 2019). Net income: €55.3m (up 25% from FY 2019). Profit margin: 11% (up from 8.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.
Analyst Estimate Surprise Post Earnings • Mar 06Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 12%. Over the next year, revenue is forecast to grow 4.3%, compared to a 42% growth forecast for the Renewable Energy industry in France.
Price Target Changed • Mar 05Price target raised to €50.86Up from €47.43, the current price target is an average from 7 analysts. The new target price is 27% above the current share price of €40.00. As of last close, the stock is up 12% over the past year.
Is New 90 Day High Low • Feb 25New 90-day low: €40.50The company is down 2.0% from its price of €41.35 on 26 November 2020. The French market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.48 per share.
분석 기사 • Feb 18Albioma (EPA:ABIO) Has Rewarded Shareholders With An Exceptional 332% Total Return On Their InvestmentWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
분석 기사 • Jan 23Is Albioma (EPA:ABIO) Likely To Turn Things Around?If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
분석 기사 • Jan 05What Kind Of Shareholders Own Albioma (EPA:ABIO)?Every investor in Albioma ( EPA:ABIO ) should be aware of the most powerful shareholder groups. Generally speaking, as...
Is New 90 Day High Low • Jan 04New 90-day high: €47.90The company is up 6.0% from its price of €45.10 on 06 October 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €20.68 per share.
분석 기사 • Dec 19At €43.80, Is It Time To Put Albioma (EPA:ABIO) On Your Watch List?Albioma ( EPA:ABIO ), is not the largest company out there, but it saw a decent share price growth in the teens level...
분석 기사 • Dec 06A Closer Look At Albioma's (EPA:ABIO) Impressive ROEOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
분석 기사 • Nov 22How Is Albioma's (EPA:ABIO) CEO Paid Relative To Peers?This article will reflect on the compensation paid to Frédéric Moyne who has served as CEO of Albioma (EPA:ABIO) since...
Price Target Changed • Oct 30Price target raised to €45.63Up from €41.20, the current price target is an average from 7 analysts. The new target price is 14% above the current share price of €39.95. As of last close, the stock is up 71% over the past year.
Is New 90 Day High Low • Oct 08New 90-day high: €45.65The company is up 16% from its price of €39.35 on 09 July 2020. The French market is flat over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Renewable Energy industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €19.25 per share.